Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives

Herein we report the synthesis and biological activity of new sigma receptor (σR) ligands obtained by combining different substituted five-membered heterocyclic rings with appropriate σR pharmacophoric amines. Radioligand binding assay, performed on guinea pig brain membranes, identified 25b (1-(1,4...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of medicinal chemistry Vol. 112; pp. 1 - 19
Main Authors Franchini, Silvia, Battisti, Umberto Maria, Prandi, Adolfo, Tait, Annalisa, Borsari, Chiara, Cichero, Elena, Fossa, Paola, Cilia, Antonio, Prezzavento, Orazio, Ronsisvalle, Simone, Aricò, Giuseppina, Parenti, Carmela, Brasili, Livio
Format Journal Article
LanguageEnglish
Published ISSY-LES-MOULINEAUX Elsevier Masson SAS 13.04.2016
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Herein we report the synthesis and biological activity of new sigma receptor (σR) ligands obtained by combining different substituted five-membered heterocyclic rings with appropriate σR pharmacophoric amines. Radioligand binding assay, performed on guinea pig brain membranes, identified 25b (1-(1,4-dioxaspiro[4.5]decan-2-ylmethyl)-4-benzylpiperazine) as the most interesting compound of the series, displaying high affinity and selectivity for σ1R (pKiσ1 = 9.13; σ1/σ2 = 47). The ability of 25b to modulate the analgesic effect of the κ agonist (−)-U-50,488H and μ agonist morphine was evaluated in vivo by radiant heat tail-flick test. It exhibited anti-opioid effects on both κ and μ receptor-mediated analgesia, suggesting an agonistic behavior at σ1R. Docking studies were performed on the theoretical σ1R homology model. The present work represents a new starting point for the design of more potent and selective σ1R ligands. [Display omitted] •Twenty-six novel σR ligands bearing a variety of five-membered heterocyclic rings were synthesized.•Compound 25b exhibited the highest affinity and selectivity (pKi σ1 = 9.13, σ1/σ2 = 47).•25b showed anti-opioid effects on κ (KOP) and μ (MOP) receptor-mediated analgesia suggesting an agonistic behavior at σ1R.•Docking studies were performed on the theoretical σ1R homology model.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0223-5234
1768-3254
DOI:10.1016/j.ejmech.2016.01.059